Patent details

EP2606891 Title: AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2606891
WO Application Number:
Type:
European Patent Granted for NL
Status:
Revoked
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12196725.1
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
12/12/2012
Grant date:
05/11/2014
EP Publication Date:
05/11/2014
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
05/11/2014
EP B1 Publication Date:
05/11/2014
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
17/12/2014
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
11/12/2032
Lapsed By Expiration Date:
Revocation Date:
06/12/2021
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
10/05/2017
 
 

 

Name:
Teva Branded Pharmaceutical Products R & D, Inc.
Address:
41 Moores Road, Frazer, Pennsylvania 19355, United States of America (US)

Historical Applicant/holder

From:
05/11/2014
To:
10/05/2017

 

Name:
Teva Branded Pharmaceutical Products, Inc.
Address:
425 Privet Road, HORSHAM 19044 PA, United States of America (US)

Domicile Holder

Name:
J.M.H. Duyver lic.
From:
05/11/2014
Address:
Gevers Patents Holidaystraat 5, B-1831, Diegem, Belgium (BE)
To:

Inventor

Name:
Zeng, Xian-Ming
Address:
MIAMI, United States of America (US)

Priority

1

Priority Patent Number:
201200525
Priority Date:
13/01/2012
Priority Country:
United Kingdom (GB)

2

Priority Patent Number:
201161577315 P
Priority Date:
19/12/2011
Priority Country:
United States of America (US)

Classification

Main IPC Class:
A61K 31/46;
IPC or IDT classification:
A61K 9/00; A61K 9/12; A61P 11/00;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
30/22
Publication date:
27/07/2022
Description:
Lapse or annulment

2

Bulletin Heading:
VB2
Journal edition number:
48/17
Publication date:
29/11/2017
Description:
Requests for restoration and notices of objection, notices of appeal to Court, notices of appeal to Council of State ex NL Patent Law 1995 in respect of which a decision has been taken. Oppositon(s) decisions ex European Patent Convention

3

Bulletin Heading:
CO
Journal edition number:
32/17
Publication date:
09/08/2017
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
EP3
Journal edition number:
2015/04
Publication date:
21/01/2015
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

5

Bulletin Heading:
EP2
Journal edition number:
2014/46
Publication date:
12/11/2014
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202230
Publication date:
27/07/2022
Description:
Revocation of the European patent

2

Issue number:
201748
Publication date:
29/11/2017
Description:
Opposition Withdrawn

3

Issue number:
201714
Publication date:
05/04/2017
Description:
Title of invention Modified

4

Issue number:
201445
Publication date:
05/11/2014
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC201701073A
Date Registered:
10/05/2017
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
J.M.H. Duyver lic.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Teva Branded Pharmaceutical Products R & D, Inc.
Address:
41 Moores Road, Frazer, Pennsylvania 19355, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
21/12/2021
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
400 Euro
Payer:
Dennemeyer and Co
Filing date Document type Document Description Number of pages File Type
04/08/2017 Outgoing Correspondence Letter registration deed 1 PDF /5/2/7/6/9/0512196725/docs/ep12196725.1_3_154507l118.pdf
10/05/2017 Request for Change First filed deed 2 PDF /5/2/7/6/9/0512196725/docs/ep12196725.1_1_rfc20170531013032758.pdf
12/01/2015 Outgoing Correspondence Outgoing Letter 1 PDF /5/2/7/6/9/0512196725/docs/ep12196725.1_0_outgoingcorrespondence20150112.pdf
17/12/2014 Outgoing Correspondence Outgoing Letter 1 PDF /5/2/7/6/9/0512196725/docs/ep12196725.1_2_outgoingcorrespondence20141217.pdf
17/12/2014 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /5/2/7/6/9/0512196725/docs/ep12196725.1_4_incomingcorrespondencepaper20141217.pdf
17/12/2014 Claims Translated claims 3 PDF /5/2/7/6/9/0512196725/docs/ep12196725.1_5_claims20141217.pdf